{"ticker": {"uuid": "af09d847-7d48-4527-b239-5888160108bc", "symbol": "COYA", "name": "Coya Therapeutics, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Discipline and Rules-Based Execution in COYA Response", "summary": "This article from Stock Traders Daily discusses the application of discipline and rules-based execution for COYA Therapeutics Inc. (NASDAQ: COYA) using AI models. It highlights three distinct trading strategies\u2014Position, Momentum Breakout, and Risk Hedging\u2014tailored to different r", "url": "https://news.stocktradersdaily.com/news_release/132/Discipline_and_Rules-Based_Execution_in_COYA_Response_072226124401_1784738641.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-22T13:11:13", "published_display": "22 Jul 2026 13:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Coya Therapeutics, Inc. \u2013 NASDAQ:COYA", "summary": "This article provides the \"Price to book forward\" value for Coya Therapeutics, Inc. (NASDAQ: COYA). While the specific value is not detailed in the provided content, the article indicates that this financial metric is available for the company on TradingView. It also lists variou", "url": "https://www.tradingview.com/symbols/NASDAQ-COYA/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-19T11:09:43", "published_display": "19 Jul 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics (COYA) Dips 1.3% as Stock Tests Key Support Levels - Bear Pennant", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQVG5zdVduYUREMDNNa1hoTExVMmJGLVU1SG9xMl9wSDZRVzY5UVZUU1JEYlo2N0xmc0h4SmVOM3BvOGN0TEx1LWVzb0hlVjU1Ulc5c1J0d3l6T2ZWVEI1S2Y5SlBqem5oNTZnbjlnaV9fNDRaMXJ2bnRoYW1fcDY2SWU0YVpHX3BRakgySm5SVFJBRlg0UFZrN0FPSERIRWJrbVRJN19WNVJXQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-18T14:33:17+00:00", "published_display": "18 Jul 2026 14:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Houston ALS Biotech Coya Eyes 2028 Approval Path", "summary": "Coya Therapeutics, a Houston-based biotech, is advancing its lead candidate COYA 302 for ALS, with a pivotal Phase 2 trial readout expected in early 2027 and potential conditional approval by the first half of 2028. The company is supported by strong analyst ratings and prominent", "url": "https://www.streetwisereports.com/article/2026/07/16/houston-als-biotech-coya-eyes-2028-approval-path.html", "source_name": "Streetwise Reports", "published_at": "2026-07-16T20:09:48", "published_display": "16 Jul 2026 20:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Targets ALS Trial Readout in Q1 2027, H.C. Wainwright Sets US$18 Price Target", "summary": "Coya Therapeutics (COYA) is a clinical-stage biopharma company focusing on treatments for ALS and dementia, with multiple analysts giving \"Buy\" ratings and price targets up to US$18. The company anticipates a significant trial readout in Q1 2027 for its ALS drug, COYA 302, with p", "url": "https://www.streetwisereports.com/article/2026/07/16/coya-targets-als-trial-readout-in-q1-2027-h-c-wainwright-sets-us-18-price-target.html", "source_name": "Streetwise Reports", "published_at": "2026-07-16T20:09:48", "published_display": "16 Jul 2026 20:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Coya Therapeutics(COYA) Stock Options Chain | Quotes & News", "summary": "This article provides details on Coya Therapeutics (COYA) stock options, including quotes and news. It specifically focuses on the company's financial instruments available for trading.", "url": "https://www.moomoo.com/stock/COYA-US/options-chain?chain_id=Name1K9-3FXPhg.1l0a440&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A64,%22f%22%3A%22www.moomoo.com%2Fcommunity%2Fprofile%2Facethebullishbully-74118294%2Fpost%2Fall%22%7D", "source_name": "Moomoo", "published_at": "2026-07-11T04:12:18", "published_display": "11 Jul 2026 04:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics (COYA) Slips 1.87% as Stock Tests Key Support Near $5.00 - Reversal Setup Alerts", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOSW9KMFhGai04X3FFZGVCR2QyUVFXMktKVVJwd3ZzcXZhQXlfOFVKcHdZRFBXQ1lYT1NIM2IzUzAwb1VsUVo5SS1CNXoxeHFOaFlMRDFja0FidWxXLTZTbWE5ZXRuejNuRlJYcE5aN1lmdmpLT1hMczVkQUtnSUwtek1GLVMtcGhhamFLY1JVd3h2T3VxM01wV3l4VXpxaUgxN0hhR0R3bFRydU5DMGkw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roth MKM Maintains Coya Therapeutics(COYA.US) With Buy Rating, Maintains Target Price $12", "summary": "Roth MKM has reiterated its Buy rating on Coya Therapeutics (COYA.US) and maintained its target price at $12. This indicates a continued positive outlook from the firm regarding the company's stock performance.", "url": "https://www.moomoo.com/news/post/72500320/roth-mkm-maintains-coya-therapeutics-coyaus-with-buy-rating-maintains", "source_name": "Moomoo", "published_at": "2026-07-07T15:12:55", "published_display": "07 Jul 2026 15:12", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics Dips 2.3% as Stock Tests Key Support at $5.42 - Max Pain Level", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPenB6c1dyVUc5TWZhT2JLRWRJQ0hhN3BIYzJ4RC1iSzBrak5qTF9WRFY0WlZveHpTb3BOVmVfWnpuVGxDeHBmbEhpRTRLRXRYTFZpUFg5bmN0Mkk0WV84T0cyaC1DeFNBazJILXpqa19Sb1pnQUlBX2F2VnoyTjRCdFYzZWdsb0pHekRmNDZDd3ZYQkhlSXNYeU9rOWJzeF90R3BF?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Coya Therapeutics, Inc. (COYA) Stock Outpacing Its Medical Peers This Year?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/coya-therapeutics-inc-coya-stock-134003613.html", "source_name": "Zacks", "published_at": "2026-06-30T13:40:03+00:00", "published_display": "30 Jun 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Behavioral Patterns of COYA and Institutional Flows", "summary": "This article analyzes Coya Therapeutics Inc. (NASDAQ: COYA), highlighting strong near and mid-term sentiment but a weak long-term outlook. It reports an ongoing breakout with potential for higher levels due to no remaining resistance. The analysis provides specific institutional ", "url": "https://news.stocktradersdaily.com/news_release/15/Behavioral_Patterns_of_COYA_and_Institutional_Flows_063026122402_1782793442.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-30T00:24:00", "published_display": "30 Jun 2026 00:24", "sentiment": "positive", "sentiment_pct": 64, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics, Inc. Actuals & Estimates (NASDAQ:COYA)", "summary": "This article provides a detailed financial overview and analyst estimates for Coya Therapeutics, Inc. (COYA), covering its income statement, balance sheet, cash flow, and valuation metrics. It highlights the stock's current price performance, analyst forecasts, historical highs a", "url": "https://www.tradingview.com/symbols/NASDAQ-COYA/forecast-actuals-and-estimates/?category=income_statement", "source_name": "TradingView", "published_at": "2026-06-27T10:10:46", "published_display": "27 Jun 2026 10:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright Maintains Coya Therapeutics(COYA.US) With Buy Rating, Maintains Target Price $18", "summary": "H.C. Wainwright has reiterated its Buy rating for Coya Therapeutics (COYA.US) and maintained a target price of $18. This indicates the firm's continued confidence in the company's prospects.", "url": "https://www.moomoo.com/news/post/72040864/hc-wainwright-maintains-coya-therapeutics-coyaus-with-buy-rating-maintains", "source_name": "Moomoo", "published_at": "2026-06-26T09:11:21", "published_display": "26 Jun 2026 09:11", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics (NASDAQ: COYA) shareholders back board nominees and 2026 auditor", "summary": "Coya Therapeutics, Inc. (NASDAQ: COYA) shareholders approved the election of two Class I directors, Secretary Wilbur Ross and Dieter Weinand, to three-year terms and ratified Weaver and Tidwell, L.L.P. as the company's independent auditor for the 2026 fiscal year at their Annual ", "url": "https://www.stocktitan.net/sec-filings/COYA/8-k-coya-therapeutics-inc-reports-material-event-581d4606d4cb.html", "source_name": "Stock Titan", "published_at": "2026-06-25T21:11:00", "published_display": "25 Jun 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "COYA Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Coya Therapeutics, Inc. (COYA) stock, including future price predictions from analysts. It covers various financial metrics, stock performance, market capitalization, and earnings information. The current stock price, historical highs and lows", "url": "https://www.tradingview.com/symbols/NASDAQ-COYA/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T14:11:00", "published_display": "25 Jun 2026 14:11", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of Coya Therapeutics, Inc. \u2013 NASDAQ:COYA", "summary": "The article focuses on Coya Therapeutics, Inc. (NASDAQ: COYA), specifically regarding the number of its shareholders. It indicates that the current data is for a specific period and includes value and percentage changes. The information is provided by TradingView, with market dat", "url": "https://www.tradingview.com/symbols/NASDAQ-COYA/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-06-23T21:11:23", "published_display": "23 Jun 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Exosomes Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Innovex Therapeutics, Coya Therapeutics, EV Therapeutics, Endosome Therapy StemXO", "summary": "The article details the Exosomes Pipeline in 2026, highlighting over 80 companies developing more than 100 exosome treatment therapies, as per DelveInsight's report. It covers emerging therapies in various clinical trial phases, recent advancements such as NurExone's spinal cord ", "url": "https://www.barchart.com/story/news/2592023/exosomes-pipeline-2026-therapies-under-investigation-clinical-trials-milestones-and-fda-approvals-by-delveinsight-innovex-therapeutics-coya-therapeutics-ev-therapeutics-endosome-therapy-stemxo", "source_name": "Barchart.com", "published_at": "2026-06-22T22:41:29", "published_display": "22 Jun 2026 22:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "COYA Technical Analysis & Stock Price Forecast", "summary": "This article provides a technical analysis and stock price forecast for Coya Therapeutics Inc (COYA), indicating an overall \"Strong Buy\" consensus based on various technical indicators. It details the company's performance against moving averages, critical support and resistance ", "url": "https://intellectia.ai/en/stock/COYA/technical", "source_name": "Intellectia AI", "published_at": "2026-06-22T08:40:57", "published_display": "22 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics Inc (COYA) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Coya Therapeutics Inc (COYA), focusing on its price momentum, support and resistance levels, and key technical indicators. The stock currently has a price momentum score of 8.62 and is trading between a resistance level of 5.32 and a ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-coya/technical", "source_name": "TradingKey", "published_at": "2026-06-18T17:39:23", "published_display": "18 Jun 2026 17:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics Inc (COYA) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides details on the dividend and stock split history for Coya Therapeutics Inc (COYA). It states that COYA has not distributed any dividends over the past five years and has no recorded stock split events. The page also includes current stock performance metrics ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-coya/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T13:09:28", "published_display": "18 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWkdoUDRJdkh3QndoZ3J2OHBvOEJlMUFEYjc1X3pLZGFXUlJ6eS1iNXhpYzNyd1NSZGxPOUdDM0xnZW9RcS1kdWNwR0xydVFVcEFGVmhfWWF5SFhYTmR5dXM0cTRIUENtbTc5bUpuNTNZQ0h0QWhMbnZDdGpfYjRWM2c3SWlCOHVJYTVoaUdDYnk2cTRKWWZTZHFvXzZDMTFmOGRUUUhyX3J6RUE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease", "summary": "Coya Therapeutics, Inc. (NASDAQ: COYA) will host a virtual webinar on June 24, 2026, at 4 p.m. ET titled \"Beyond the Hit: How Repetitive Head Trauma, Inflammation, and Neurodegenerative Disease Intersect.\" The webinar will feature experts such as Stanley H. Appel, M.D., Fred Gros", "url": "https://www.businesswire.com/news/home/20260615899187/en/Coya-Therapeutics-to-Host-Virtual-Webinar-on-the-Intersection-of-Repetitive-Head-Trauma-Brain-Inflammation-and-Neurodegenerative-Disease", "source_name": "Business Wire", "published_at": "2026-06-16T04:11:19", "published_display": "16 Jun 2026 04:11", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Coya Therapeutics, Inc. SEC Filing (May 13, 2026)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPN2VTdEFpdzZQdkRybFpnM1hWV00xTWZfdEV5SVZCV0NUb3lJbDhHX0lBNjA3MlFldDJFajROaHBFaDcwWlRUNFI3UzNNTTdLNURmM2pDQmp6YkpSaUp2a0J1WEdlQ2J5N2tpZU9KX2JwLTdjRHZoOHJZSWN2cXJaQ2I2N1JDWTFUcDZ3bEJGcmlNVW5JLVhFVVFFY3F5cEU?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Coya Therapeutics (NASDAQ:COYA) In A Good Position To Invest In Growth?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-16T07:00:00+00:00", "published_display": "16 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MindWalk Holdings (HYFT) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1zeFpXOTR3d3lRd3Mxc1dQRWFxTDNyQ1c3aTlpTjh5S0FyTl93Y1UxU0czSERFa1M3T3Fzc3JLdUNCVlhHbWJ2Z0wwemh2Tkp0dlpr?oc=5", "source_name": "Stock Titan", "published_at": "2025-09-10T12:23:07+00:00", "published_display": "10 Sep 2025 12:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE9DQkg0dTZYeWZ4WXhZM3JYbXhWYjFsYW1TZ1RWQ2hqcXkyenE2U0pfVHIyeWNTczlXdDJITk9QY291WUVMV0xxMzFaS1JLdTlG?oc=5", "source_name": "CNN", "published_at": "2024-02-12T21:25:08+00:00", "published_display": "12 Feb 2024 21:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics, Inc. Announces Closing of $15.25 Million Initial Public Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNTnVoZXBtMk0xbWE0bFR5QlJZYnpHbWRRZEtKQ3JzVnl1ZXFvUldsQWRhQnFPVjJJeEdmdF9vMFVZT3R6VTladXNuemo0VWY4bzF4aEtjdnU4dXdWczQ5c20zTm1vdk5aLXlMMDZfdzFxQ0pYMXczdDc0VDFJQnFiZ2ZjblFsQnZkSXhIMXIzNGdEc09udVZGOGJOV1Z1b1RTTTJhQw?oc=5", "source_name": "IPO Edge", "published_at": "2023-01-12T03:12:48+00:00", "published_display": "12 Jan 2023 03:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics (COYA) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBrRGRSdnVLQXkxZnZRUkVpUVlTTlc4SlNBRnU5ek05Z1VlWnF5TTlIbS1LZl90RHhyLURKOHB5a0hNYmdRZHc0V3JxQm1LLVVFNVJUajdKM2lzUQ?oc=5", "source_name": "MarketBeat", "published_at": "2022-12-30T01:27:06+00:00", "published_display": "30 Dec 2022 01:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Discipline and Rules-Based Execution in COYA Response", "summary": "This article from Stock Traders Daily discusses the application of discipline and rules-based execution for COYA Therapeutics Inc. (NASDAQ: COYA) using AI models. It highlights three distinct trading strategies\u2014Position, Momentum Breakout, and Risk Hedging\u2014tailored to different r", "url": "https://news.stocktradersdaily.com/news_release/132/Discipline_and_Rules-Based_Execution_in_COYA_Response_072226124401_1784738641.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-22T13:11:13", "published_display": "22 Jul 2026 13:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Coya Therapeutics, Inc. \u2013 NASDAQ:COYA", "summary": "This article provides the \"Price to book forward\" value for Coya Therapeutics, Inc. (NASDAQ: COYA). While the specific value is not detailed in the provided content, the article indicates that this financial metric is available for the company on TradingView. It also lists variou", "url": "https://www.tradingview.com/symbols/NASDAQ-COYA/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-19T11:09:43", "published_display": "19 Jul 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics (COYA) Dips 1.3% as Stock Tests Key Support Levels - Bear Pennant", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQVG5zdVduYUREMDNNa1hoTExVMmJGLVU1SG9xMl9wSDZRVzY5UVZUU1JEYlo2N0xmc0h4SmVOM3BvOGN0TEx1LWVzb0hlVjU1Ulc5c1J0d3l6T2ZWVEI1S2Y5SlBqem5oNTZnbjlnaV9fNDRaMXJ2bnRoYW1fcDY2SWU0YVpHX3BRakgySm5SVFJBRlg0UFZrN0FPSERIRWJrbVRJN19WNVJXQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-18T14:33:17+00:00", "published_display": "18 Jul 2026 14:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Houston ALS Biotech Coya Eyes 2028 Approval Path", "summary": "Coya Therapeutics, a Houston-based biotech, is advancing its lead candidate COYA 302 for ALS, with a pivotal Phase 2 trial readout expected in early 2027 and potential conditional approval by the first half of 2028. The company is supported by strong analyst ratings and prominent", "url": "https://www.streetwisereports.com/article/2026/07/16/houston-als-biotech-coya-eyes-2028-approval-path.html", "source_name": "Streetwise Reports", "published_at": "2026-07-16T20:09:48", "published_display": "16 Jul 2026 20:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Targets ALS Trial Readout in Q1 2027, H.C. Wainwright Sets US$18 Price Target", "summary": "Coya Therapeutics (COYA) is a clinical-stage biopharma company focusing on treatments for ALS and dementia, with multiple analysts giving \"Buy\" ratings and price targets up to US$18. The company anticipates a significant trial readout in Q1 2027 for its ALS drug, COYA 302, with p", "url": "https://www.streetwisereports.com/article/2026/07/16/coya-targets-als-trial-readout-in-q1-2027-h-c-wainwright-sets-us-18-price-target.html", "source_name": "Streetwise Reports", "published_at": "2026-07-16T20:09:48", "published_display": "16 Jul 2026 20:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics(COYA) Stock Options Chain | Quotes & News", "summary": "This article provides details on Coya Therapeutics (COYA) stock options, including quotes and news. It specifically focuses on the company's financial instruments available for trading.", "url": "https://www.moomoo.com/stock/COYA-US/options-chain?chain_id=Name1K9-3FXPhg.1l0a440&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A64,%22f%22%3A%22www.moomoo.com%2Fcommunity%2Fprofile%2Facethebullishbully-74118294%2Fpost%2Fall%22%7D", "source_name": "Moomoo", "published_at": "2026-07-11T04:12:18", "published_display": "11 Jul 2026 04:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics (COYA) Slips 1.87% as Stock Tests Key Support Near $5.00 - Reversal Setup Alerts", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOSW9KMFhGai04X3FFZGVCR2QyUVFXMktKVVJwd3ZzcXZhQXlfOFVKcHdZRFBXQ1lYT1NIM2IzUzAwb1VsUVo5SS1CNXoxeHFOaFlMRDFja0FidWxXLTZTbWE5ZXRuejNuRlJYcE5aN1lmdmpLT1hMczVkQUtnSUwtek1GLVMtcGhhamFLY1JVd3h2T3VxM01wV3l4VXpxaUgxN0hhR0R3bFRydU5DMGkw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roth MKM Maintains Coya Therapeutics(COYA.US) With Buy Rating, Maintains Target Price $12", "summary": "Roth MKM has reiterated its Buy rating on Coya Therapeutics (COYA.US) and maintained its target price at $12. This indicates a continued positive outlook from the firm regarding the company's stock performance.", "url": "https://www.moomoo.com/news/post/72500320/roth-mkm-maintains-coya-therapeutics-coyaus-with-buy-rating-maintains", "source_name": "Moomoo", "published_at": "2026-07-07T15:12:55", "published_display": "07 Jul 2026 15:12", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics Dips 2.3% as Stock Tests Key Support at $5.42 - Max Pain Level", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPenB6c1dyVUc5TWZhT2JLRWRJQ0hhN3BIYzJ4RC1iSzBrak5qTF9WRFY0WlZveHpTb3BOVmVfWnpuVGxDeHBmbEhpRTRLRXRYTFZpUFg5bmN0Mkk0WV84T0cyaC1DeFNBazJILXpqa19Sb1pnQUlBX2F2VnoyTjRCdFYzZWdsb0pHekRmNDZDd3ZYQkhlSXNYeU9rOWJzeF90R3BF?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Coya Therapeutics, Inc. (COYA) Stock Outpacing Its Medical Peers This Year?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/coya-therapeutics-inc-coya-stock-134003613.html", "source_name": "Zacks", "published_at": "2026-06-30T13:40:03+00:00", "published_display": "30 Jun 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Behavioral Patterns of COYA and Institutional Flows", "summary": "This article analyzes Coya Therapeutics Inc. (NASDAQ: COYA), highlighting strong near and mid-term sentiment but a weak long-term outlook. It reports an ongoing breakout with potential for higher levels due to no remaining resistance. The analysis provides specific institutional ", "url": "https://news.stocktradersdaily.com/news_release/15/Behavioral_Patterns_of_COYA_and_Institutional_Flows_063026122402_1782793442.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-30T00:24:00", "published_display": "30 Jun 2026 00:24", "sentiment": "positive", "sentiment_pct": 64, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics, Inc. Actuals & Estimates (NASDAQ:COYA)", "summary": "This article provides a detailed financial overview and analyst estimates for Coya Therapeutics, Inc. (COYA), covering its income statement, balance sheet, cash flow, and valuation metrics. It highlights the stock's current price performance, analyst forecasts, historical highs a", "url": "https://www.tradingview.com/symbols/NASDAQ-COYA/forecast-actuals-and-estimates/?category=income_statement", "source_name": "TradingView", "published_at": "2026-06-27T10:10:46", "published_display": "27 Jun 2026 10:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright Maintains Coya Therapeutics(COYA.US) With Buy Rating, Maintains Target Price $18", "summary": "H.C. Wainwright has reiterated its Buy rating for Coya Therapeutics (COYA.US) and maintained a target price of $18. This indicates the firm's continued confidence in the company's prospects.", "url": "https://www.moomoo.com/news/post/72040864/hc-wainwright-maintains-coya-therapeutics-coyaus-with-buy-rating-maintains", "source_name": "Moomoo", "published_at": "2026-06-26T09:11:21", "published_display": "26 Jun 2026 09:11", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics (NASDAQ: COYA) shareholders back board nominees and 2026 auditor", "summary": "Coya Therapeutics, Inc. (NASDAQ: COYA) shareholders approved the election of two Class I directors, Secretary Wilbur Ross and Dieter Weinand, to three-year terms and ratified Weaver and Tidwell, L.L.P. as the company's independent auditor for the 2026 fiscal year at their Annual ", "url": "https://www.stocktitan.net/sec-filings/COYA/8-k-coya-therapeutics-inc-reports-material-event-581d4606d4cb.html", "source_name": "Stock Titan", "published_at": "2026-06-25T21:11:00", "published_display": "25 Jun 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "COYA Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Coya Therapeutics, Inc. (COYA) stock, including future price predictions from analysts. It covers various financial metrics, stock performance, market capitalization, and earnings information. The current stock price, historical highs and lows", "url": "https://www.tradingview.com/symbols/NASDAQ-COYA/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T14:11:00", "published_display": "25 Jun 2026 14:11", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of Coya Therapeutics, Inc. \u2013 NASDAQ:COYA", "summary": "The article focuses on Coya Therapeutics, Inc. (NASDAQ: COYA), specifically regarding the number of its shareholders. It indicates that the current data is for a specific period and includes value and percentage changes. The information is provided by TradingView, with market dat", "url": "https://www.tradingview.com/symbols/NASDAQ-COYA/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-06-23T21:11:23", "published_display": "23 Jun 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Exosomes Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Innovex Therapeutics, Coya Therapeutics, EV Therapeutics, Endosome Therapy StemXO", "summary": "The article details the Exosomes Pipeline in 2026, highlighting over 80 companies developing more than 100 exosome treatment therapies, as per DelveInsight's report. It covers emerging therapies in various clinical trial phases, recent advancements such as NurExone's spinal cord ", "url": "https://www.barchart.com/story/news/2592023/exosomes-pipeline-2026-therapies-under-investigation-clinical-trials-milestones-and-fda-approvals-by-delveinsight-innovex-therapeutics-coya-therapeutics-ev-therapeutics-endosome-therapy-stemxo", "source_name": "Barchart.com", "published_at": "2026-06-22T22:41:29", "published_display": "22 Jun 2026 22:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "COYA Technical Analysis & Stock Price Forecast", "summary": "This article provides a technical analysis and stock price forecast for Coya Therapeutics Inc (COYA), indicating an overall \"Strong Buy\" consensus based on various technical indicators. It details the company's performance against moving averages, critical support and resistance ", "url": "https://intellectia.ai/en/stock/COYA/technical", "source_name": "Intellectia AI", "published_at": "2026-06-22T08:40:57", "published_display": "22 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics Inc (COYA) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Coya Therapeutics Inc (COYA), focusing on its price momentum, support and resistance levels, and key technical indicators. The stock currently has a price momentum score of 8.62 and is trading between a resistance level of 5.32 and a ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-coya/technical", "source_name": "TradingKey", "published_at": "2026-06-18T17:39:23", "published_display": "18 Jun 2026 17:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics Inc (COYA) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides details on the dividend and stock split history for Coya Therapeutics Inc (COYA). It states that COYA has not distributed any dividends over the past five years and has no recorded stock split events. The page also includes current stock performance metrics ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-coya/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T13:09:28", "published_display": "18 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWkdoUDRJdkh3QndoZ3J2OHBvOEJlMUFEYjc1X3pLZGFXUlJ6eS1iNXhpYzNyd1NSZGxPOUdDM0xnZW9RcS1kdWNwR0xydVFVcEFGVmhfWWF5SFhYTmR5dXM0cTRIUENtbTc5bUpuNTNZQ0h0QWhMbnZDdGpfYjRWM2c3SWlCOHVJYTVoaUdDYnk2cTRKWWZTZHFvXzZDMTFmOGRUUUhyX3J6RUE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease", "summary": "Coya Therapeutics, Inc. (NASDAQ: COYA) will host a virtual webinar on June 24, 2026, at 4 p.m. ET titled \"Beyond the Hit: How Repetitive Head Trauma, Inflammation, and Neurodegenerative Disease Intersect.\" The webinar will feature experts such as Stanley H. Appel, M.D., Fred Gros", "url": "https://www.businesswire.com/news/home/20260615899187/en/Coya-Therapeutics-to-Host-Virtual-Webinar-on-the-Intersection-of-Repetitive-Head-Trauma-Brain-Inflammation-and-Neurodegenerative-Disease", "source_name": "Business Wire", "published_at": "2026-06-16T04:11:19", "published_display": "16 Jun 2026 04:11", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics, Inc. SEC Filing (May 13, 2026)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPN2VTdEFpdzZQdkRybFpnM1hWV00xTWZfdEV5SVZCV0NUb3lJbDhHX0lBNjA3MlFldDJFajROaHBFaDcwWlRUNFI3UzNNTTdLNURmM2pDQmp6YkpSaUp2a0J1WEdlQ2J5N2tpZU9KX2JwLTdjRHZoOHJZSWN2cXJaQ2I2N1JDWTFUcDZ3bEJGcmlNVW5JLVhFVVFFY3F5cEU?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Coya Therapeutics (NASDAQ:COYA) In A Good Position To Invest In Growth?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-16T07:00:00+00:00", "published_display": "16 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MindWalk Holdings (HYFT) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1zeFpXOTR3d3lRd3Mxc1dQRWFxTDNyQ1c3aTlpTjh5S0FyTl93Y1UxU0czSERFa1M3T3Fzc3JLdUNCVlhHbWJ2Z0wwemh2Tkp0dlpr?oc=5", "source_name": "Stock Titan", "published_at": "2025-09-10T12:23:07+00:00", "published_display": "10 Sep 2025 12:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE9DQkg0dTZYeWZ4WXhZM3JYbXhWYjFsYW1TZ1RWQ2hqcXkyenE2U0pfVHIyeWNTczlXdDJITk9QY291WUVMV0xxMzFaS1JLdTlG?oc=5", "source_name": "CNN", "published_at": "2024-02-12T21:25:08+00:00", "published_display": "12 Feb 2024 21:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics, Inc. Announces Closing of $15.25 Million Initial Public Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNTnVoZXBtMk0xbWE0bFR5QlJZYnpHbWRRZEtKQ3JzVnl1ZXFvUldsQWRhQnFPVjJJeEdmdF9vMFVZT3R6VTladXNuemo0VWY4bzF4aEtjdnU4dXdWczQ5c20zTm1vdk5aLXlMMDZfdzFxQ0pYMXczdDc0VDFJQnFiZ2ZjblFsQnZkSXhIMXIzNGdEc09udVZGOGJOV1Z1b1RTTTJhQw?oc=5", "source_name": "IPO Edge", "published_at": "2023-01-12T03:12:48+00:00", "published_display": "12 Jan 2023 03:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Coya Therapeutics (COYA) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBrRGRSdnVLQXkxZnZRUkVpUVlTTlc4SlNBRnU5ek05Z1VlWnF5TTlIbS1LZl90RHhyLURKOHB5a0hNYmdRZHc0V3JxQm1LLVVFNVJUajdKM2lzUQ?oc=5", "source_name": "MarketBeat", "published_at": "2022-12-30T01:27:06+00:00", "published_display": "30 Dec 2022 01:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 86, "total_relevant": 47, "sentiment_summary": {"positive": 17, "negative": 2, "neutral": 28, "score": 57, "total": 47, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 13.35, "count": 23}, {"event": "earnings", "label": "Earnings", "weight": 6.95, "count": 14}, {"event": "analyst", "label": "Analyst action", "weight": 2.75, "count": 5}, {"event": "guidance", "label": "Guidance", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 17, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 4.54, "latest_week": "2026-07-17", "one_week_move": -13.7, "four_week_move": -7.7, "twelve_week_move": 5.1, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.249782, "market_dynamics_buy_signal": false, "relative_strength": -23.79971, "fair_value_gap": -24.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 54.8093, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-13.7% over one week, -7.7% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 66, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "TradingView", "count": 6}, {"label": "dars.gov.et", "count": 3}, {"label": "Moomoo", "count": 3}, {"label": "Stock Titan", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "Stock Traders Daily", "count": 2}, {"label": "Streetwise Reports", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 39}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 23}, {"label": "Earnings", "count": 14}, {"label": "Analyst action", "count": 5}, {"label": "Guidance", "count": 3}, {"label": "Regulatory and legal", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "57/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "39", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-13.7% over one week, -7.7% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Discipline and Rules-Based Execution in COYA Response"}], "updated_at": "2026-07-23T05:37:05.548976+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}